IL18 and acute myeloid leukemia: Specifically, genetically predicted higher levels of circulating IL-18 was associated with a decreased risk of acute myeloid leukemia (OR=0.55, 95% CI: 0.43-0.69, P=5.39×10-7, per 1 standard deviation (SD) increase).